We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cumberland Pharmaceutical Inc | NASDAQ:CPIX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.07 | 4.64% | 1.58 | 1.45 | 1.85 | 1.6499 | 1.575 | 1.58 | 9,703 | 22:33:35 |
|
|
Date of Report (Date of Earliest Event Reported): September 29, 2017 (September 25, 2017)
|
|
|||
Tennessee
|
001-33637
|
62-1765329
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
2525 West End Avenue, Suite 950, Nashville, Tennessee
|
|
37203
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
||
Registrant's telephone number, including area code: (615) 255-0068
|
|
|
|
|
|
|
|
|
Cumberland Pharmaceuticals Inc.
|
|
|
|
|
September 29, 2017
|
By: Michael Bonner
|
|
|
|
|
|
Name: Michael Bonner
|
|
|
Title: Chief Financial Officer
|
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press release dated September 25, 2017
|
|
|
|
1 Year Cumberland Pharmaceutical Chart |
1 Month Cumberland Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions